Home›Insulin Degludec And Liraglutide›Insulin Degludec And Liraglutide + Estrogens

Does Insulin Degludec And Liraglutide Interact with Estrogens?

Moderate interaction. May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.

Source & how this summary was prepared

This interaction summary was extracted from FDA drug labeling through openFDA, using automated processing and AI assistance. NIH/NLM RxNorm helps organize drug names.

Read the saved source label on DailyMed →

A separate current-label comparison has not been recorded for this page. Read about our extraction process.

Interaction classification
Moderate
Insulin Degludec And Liraglutide Class
Insulin Analog
Management
Confirm exact products with your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Insulin Degludec And Liraglutide and your doctor is considering prescribing Estrogens (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Insulin Degludec And Liraglutide(Xultophy 100/3.6)+💊 Estrogens

Severity & Interaction Details

🟡
moderate
Moderate interaction
Read the interaction summary and source below. Use this information to discuss your medication list with your care team.
Severity scale
MinorContra
On record
Yes
Drug A class
Insulin Analog
Drug B class
—
Source
NLP:insulin degludec and liraglutide

What this means in plain English

May decrease blood glucose-lowering effect; dosage increases and increased glucose monitoring may be required.

About Insulin Degludec And Liraglutide and Estrogens

Insulin Degludec And Liraglutide is an Insulin Analog. Insulin Degludec And Liraglutide additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:insulin degludec and liraglutide

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check the medicines you actually take

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

FDA data. NIH drug identities. Plain-language explanations by CDI. Prepared with automated extraction and AI assistance; curated references are identified separately. How we prepare the information · Suggest a correction

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations